To study the effect of Probiotics Bacillus subtilis on Diarrhoea due to antibiotics
Phase 4
- Conditions
- Health Condition 1: null- Patients having taken antibiotics within four weeks prior to enrollment
- Registration Number
- CTRI/2018/01/011186
- Lead Sponsor
- Synergia Life Sciences Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Male and female aged 18 to 65.
2.Stable ECG.
3.Willing to give informed consent
Exclusion Criteria
1.Sero positive patients.
2.Pregnancy.
3.Subjects who are on other Probiotics or prebiotics.
4.Subjects who are addicted to tobacco, alcohol.
5.Subjects who are on any other medication than prescribed oral antibiotics.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the role of Probiotic- Bacillus subtilis HU58 in Antibiotic associated Diarrhoea in Humans in comparison to placeboTimepoint: 15 days
- Secondary Outcome Measures
Name Time Method Safety and tolerability; clinical variablesTimepoint: 15 days